Johnson & Johnson (NYSE:JNJ) closed its last session at $122.85 with the change of +0.28%. The market capitalization of the company is $337.92B with an average Volume of 7.24 million shares. The stock currently has its 52-Week High range of $123.23 and 52-week low range of $81.79. The Price to Book (P/B) ratio stands at 4.64. The stock traded total quantity of 6.13 million shares.
For the current Fiscal Quarter, 19 analysts have given an average earnings per share forecast of $1.68. The Low Earnings per share estimate of the current Quarter is $1.63 and High Estimate is set at $1.79 according to these Analysts opinions. The Previous Year EPS of this Quarter is $1.71.
According to 16 analysts, an average sales Estimate of the current Fiscal quarter is $17.99B. The lower sales estimate is $17.74B and higher sales estimate is $18.20B according to these Analysts thoughts.
The Company currently has Highest Price Target of $126 and Lowest Price Target of $105. It has Median Price Targets of $120.5. Mean price target is set at $118.56 after consensus analysis of 18 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 3 analysts have assigned this stock as Strong Buy where 7 assigned Buy, 12 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
ResMed Inc. (NYSE:RMD) ended its last trade at $64.51 with the move of +1.83%. The company has market value of $9.06B with the total traded volume of 1.36 million. The stock currently has its 52-Week top value of $64.57 and 52-week down value of $48.99. The price to book (P/B) ratio of the company is 5.31. Its previous closing price was recorded at $63.35.
For the current Fiscal Quarter, 11 analysts have given an Average earnings estimate of $0.74 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $0.69 while High Estimate is $0.76. The Previous Year EPS of this Quarter is $0.68.
According to 12 analysts, an Average Revenue Estimate of the current Fiscal quarter is $512.21M. According to them, the Low Revenue estimate is $491.00M and High Revenue estimate is $529.50M.
The Company currently has High Price Target of $73.5. The Low and Mean Price Targets are $44 and $59.06 respectively. These price targets are set after consensus analysis of 11 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 1 analysts have given this stock as Strong Buy where 4 issued Buy, 8 analysts think that it’s a Hold, 2 told Underperform and0 assigned Sell rating.